DK452178A - R fremgangsmaade til fremstilling af phenylethanolamin-derivate - Google Patents

R fremgangsmaade til fremstilling af phenylethanolamin-derivate

Info

Publication number
DK452178A
DK452178A DK452178A DK452178A DK452178A DK 452178 A DK452178 A DK 452178A DK 452178 A DK452178 A DK 452178A DK 452178 A DK452178 A DK 452178A DK 452178 A DK452178 A DK 452178A
Authority
DK
Denmark
Prior art keywords
preparing
procedure
phenylethanolamine derivatives
phenylethanolamine
derivatives
Prior art date
Application number
DK452178A
Other languages
English (en)
Other versions
DK168484B1 (da
Inventor
K Imai
K Niigata
T Fujikura
S Hashimoto
T Takenaka
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12203477A external-priority patent/JPS5473751A/ja
Priority claimed from JP12843677A external-priority patent/JPS5463048A/ja
Priority claimed from JP15535277A external-priority patent/JPS5495544A/ja
Priority claimed from JP7496478A external-priority patent/JPS552639A/ja
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of DK452178A publication Critical patent/DK452178A/da
Application granted granted Critical
Publication of DK168484B1 publication Critical patent/DK168484B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/34Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK452178A 1977-10-12 1978-10-11 Analogifremgangsmåde til fremstilling af phenylethanolaminderivater eller fysiologisk accetable syreadditionssalte deraf DK168484B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP12203477 1977-10-12
JP12203477A JPS5473751A (en) 1977-10-12 1977-10-12 Phenyl ethanolamine derivatives and their preparation
JP12843677 1977-10-26
JP12843677A JPS5463048A (en) 1977-10-26 1977-10-26 Novel phenyl ethanolamine derivatives and their preparation
JP15535277 1977-12-23
JP15535277A JPS5495544A (en) 1977-12-23 1977-12-23 Phenylethanolamine derivative and its preparation
JP7496478 1978-06-21
JP7496478A JPS552639A (en) 1978-06-21 1978-06-21 Phenylethanolamine derivative and its preparation

Publications (2)

Publication Number Publication Date
DK452178A true DK452178A (da) 1979-04-13
DK168484B1 DK168484B1 (da) 1994-04-05

Family

ID=27465764

Family Applications (1)

Application Number Title Priority Date Filing Date
DK452178A DK168484B1 (da) 1977-10-12 1978-10-11 Analogifremgangsmåde til fremstilling af phenylethanolaminderivater eller fysiologisk accetable syreadditionssalte deraf

Country Status (16)

Country Link
US (1) US4217305A (da)
AT (1) AT363457B (da)
AU (1) AU526715B2 (da)
CA (1) CA1147342A (da)
CH (1) CH639948A5 (da)
DE (1) DE2843016A1 (da)
DK (1) DK168484B1 (da)
ES (2) ES474149A1 (da)
FR (1) FR2405931A1 (da)
GB (1) GB2006772B (da)
GR (1) GR65337B (da)
IT (1) IT1160853B (da)
NO (1) NO147148C (da)
PT (1) PT68624A (da)
SE (1) SE448232B (da)
SU (2) SU982537A3 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55124742A (en) * 1979-03-20 1980-09-26 Kyowa Hakko Kogyo Co Ltd Novel aminoalcohol derivative
US4206125A (en) * 1979-05-04 1980-06-03 Richardson-Merrell Inc. 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives
DD202692A5 (de) * 1979-12-04 1983-09-28 Ciba Geigy Verfahren zur herstellung neuer derivate des 2-amino-aethanols
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US4558156A (en) * 1980-02-08 1985-12-10 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives
DE3128117A1 (de) * 1980-07-29 1982-03-11 Yamanouchi Pharmaceutical Co., Ltd., Tokyo Neue phenyl-aethylaminderivate, verfahren zu ihrer herstellung
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
DE3564569D1 (en) * 1984-05-15 1988-09-29 Seitetsu Kagaku Co Ltd Process for preparing 2-alkyl-5-haloacetylbenzenesulfonamide
US4678855A (en) * 1985-10-09 1987-07-07 Merck & Co., Inc. Substituted benzenesulfonamides
JPS62114952A (ja) * 1985-11-13 1987-05-26 Yamanouchi Pharmaceut Co Ltd 置換フエネチルアミン誘導体の製造法
EP0317206B1 (en) * 1987-11-13 1993-04-28 Glaxo Group Limited Phenethanolamine derivatives
CA2136321A1 (en) * 1992-05-22 1993-12-09 Takahiro Ogawa Pharmaceutical composition for use in glaucoma treatment
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
AU715233B2 (en) * 1996-01-10 2000-01-20 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same
JP2002513799A (ja) * 1998-05-06 2002-05-14 デューク・ユニバーシティー 膀胱および下部尿路症候群の治療方法
FR2791675B1 (fr) * 1999-03-30 2001-05-04 Synthelabo Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique
US6835853B2 (en) * 2001-10-31 2004-12-28 Synthon Bv Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
NZ577031A (en) 2003-05-30 2010-09-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-CO inhibitors
JP2007513943A (ja) * 2003-12-09 2007-05-31 シージェイ コーポレーション 光学的に純粋なフェネチルアミン誘導体の調製方法
MX2007005137A (es) * 2004-11-23 2007-06-22 Warner Lambert Co Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia.
CN100569745C (zh) * 2005-05-27 2009-12-16 国际威林生化科技股份有限公司 制备坦舒乐欣的方法
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
WO2007054896A1 (en) 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP2026766A1 (en) 2006-05-17 2009-02-25 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
CN102050766B (zh) * 2009-11-03 2013-08-07 安徽省新星药物开发有限责任公司 一种盐酸氨磺洛尔的合成方法
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
RS66416B1 (sr) 2019-01-18 2025-02-28 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i metode njegove primene

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3701808A (en) * 1967-12-21 1972-10-31 Allen & Hanburys Ltd Phenylethanolamines
GB1266058A (da) 1969-07-08 1972-03-08
GB1321701A (en) 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
US3711545A (en) * 1971-02-23 1973-01-16 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-sulfamoylaminobenzyl alcohols
DE2115926C3 (de) * 1971-04-01 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel
US4034112A (en) * 1973-06-22 1977-07-05 Imperial Chemical Industries Limited Ethanolamine derivatives having β-adrenergic blocking activity
US3860647A (en) * 1973-08-20 1975-01-14 Smithkline Corp {60 -Aminomethyl-4-hydroxy-3-sulfamyl-benzyl alcohols and 4-hydroxy-3-sulfamyl phenethylamines
DK31578A (da) * 1977-02-03 1978-08-04 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af benzenderivater
GB1593651A (en) * 1977-02-03 1981-07-22 Allen & Hanburys Ltd Amides

Also Published As

Publication number Publication date
GB2006772B (en) 1982-02-03
NO147148C (no) 1983-02-09
IT7869350A0 (it) 1978-10-11
DE2843016C2 (da) 1988-10-13
PT68624A (en) 1978-11-01
ES474149A1 (es) 1979-10-16
GR65337B (en) 1980-08-18
CH639948A5 (de) 1983-12-15
DK168484B1 (da) 1994-04-05
AT363457B (de) 1981-08-10
NO783442L (no) 1979-04-18
AU526715B2 (en) 1983-01-27
IT1160853B (it) 1987-03-11
FR2405931A1 (fr) 1979-05-11
SE7810613L (sv) 1979-04-13
GB2006772A (en) 1979-05-10
ES481549A1 (es) 1980-04-01
CA1147342A (en) 1983-05-31
SU982537A3 (ru) 1982-12-15
SE448232B (sv) 1987-02-02
ATA731778A (de) 1981-01-15
US4217305A (en) 1980-08-12
DE2843016A1 (de) 1979-04-26
AU4064278A (en) 1980-04-17
SU932982A3 (ru) 1982-05-30
NO147148B (no) 1982-11-01
FR2405931B1 (da) 1982-11-19

Similar Documents

Publication Publication Date Title
DK452178A (da) R fremgangsmaade til fremstilling af phenylethanolamin-derivate
DK155733C (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidinderivater
DK349478A (da) Fremgangsmaade til fremstilling af oligoimider
DK195378A (da) Fremgangsmaade til fremstilling af polyenforbindelser
DK269178A (da) Analogifremgangsmaade til fremstilling af n-alkylpiperidinderivater
DK539578A (da) Fremgangsmaade til fremstilling af pleuromutilinglycsid-derivater
DK536178A (da) Fremgangsmaade til fremstilling af stilbenderivater
DK155279C (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidinderivater
DK531178A (da) Fremgangsmaade til fremstilling af phenylglycinderivater
DK30578A (da) Fremgangsmaade til fremstilling af aminoalkoxyphenylderivater
DK470978A (da) R fremgangsmaade til fremstilling af pyrazinobenzoxapinderivate
DK494978A (da) Fremgangsmaade til fremstilling af 2-iminoimidazolidinderivater
DK152130C (da) Fremgangsmaade til fremstilling af benzooebaathienopyridinderivater
DK50778A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
DK97578A (da) Fremgangsmaade til fremstilling af benzylpyrimidin-forbindelser
DK50878A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
DK520178A (da) Fremgangsmaade til fremstilling af phenoxyalkanolamin-derivater
DK385478A (da) Fremgangsmaade til fremstilling af dibenzocycloocteniminer
DK246878A (da) Fremgangsmaade til fremstilling af acylderivater
DK61778A (da) Fremgangsmaade til fremstilling af everninominderivater
DK570578A (da) Fremgangsmaade til fremstilling af 21-hydroxy-20-methyl-pregnan-derivater
DK190178A (da) Fremgangsmaade til fremstilling af pyranoquinolinon-derivater
DK144884C (da) Fremgangsmaade til fremstilling af 3-bromphthalid
DK351478A (da) Fremgangsmaade til fremstilling af apovincamin
DK521578A (da) Fremgangsmaade til fremstilling af phenylbutenoner